We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New System Keeps Heart Tissue Alive Longer to Enable Extensive Drug Testing
News

New System Keeps Heart Tissue Alive Longer to Enable Extensive Drug Testing

New System Keeps Heart Tissue Alive Longer to Enable Extensive Drug Testing
News

New System Keeps Heart Tissue Alive Longer to Enable Extensive Drug Testing

Heart slices in the physiological biomimetic culture system developed at UofL. Credit: University of Louisville
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "New System Keeps Heart Tissue Alive Longer to Enable Extensive Drug Testing"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Researchers at the University of Louisville have developed an easily reproducible system that enables them to keep slices of human hearts alive for a longer period of time, allowing more extensive testing of new drugs and gene therapies.

This new biomimetic culture system mimics the environment of a living organ through continuous electrical stimulation and oxygenation, maintaining viability and functionality of the heart segments for six days. Previous culture systems maintained functional heart slices for no more than 24 hours. The extended viability time will enable improved preclinical testing of new drugs for effectiveness and toxicity.

"This new method maintains fully functional human heart slices for six days in the culture environment. This facilitates testing efficacy of heart failure therapeutics and cardiotoxins on human heart tissue with no need for a living human," said Tamer M. A. Mohamed, Ph.D., who led the research.

The system provides access to the complete 3D multicellular system that reflects the heart's functional and structural condition in a living person.

"This system will save time and costs of clinical trials during phase one research, which includes testing for toxicity and proof of efficacy," Mohamed said. "In addition to drugs, we have demonstrated the system's effectiveness in testing gene therapy."

The optimized medium for sustaining the heart tissue slices is described in an article published online last week in Circulation Research, a publication of the American Heart Association. It will appear in the August 30, 2019, print and online issue. Along with Mohamed, the research was conducted by Qinghui Ou, B.Sc., Riham R.E. Abouleisa, Ph.D., and others at UofL, along with colleagues in California, Colorado, the United Kingdom, Germany and Egypt. UofL has a provisional patent application on this technology.

Reference: Qinghui Ou, et al. A Physiological Biomimetic Culture System for Pig and Human Heart Slices. Circulation Research. (2019) DOI: https://doi.org/10.1161/CIRCRESAHA.119.314996

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement